Optical Coherence Tomography of Airway and Pleural Disorders

Disorder of Pleura and Pleural Cavity Clinical Trial

Official title:

Optical Coherence Tomography of Airway and Pleural Disorders

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00580892
• Other study ID #: 20064982
• Status: Withdrawn
• Start date: July 2007
• Est. completion date: July 2018

Study information

• Verified date: October 2022
• Source: University of California, Irvine
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The researcher can use Optical coherence tomography a near-infrared diode to emit light that can produce images of the specimen under investigation and provide information about tissue abnormalities without causing damage.

Description:

The researcher can use Optical coherence tomography endoscopic imaging to improve diagnosis and treatment of airway and pleural malignancy. In the events of burn injury and smoke inhalation injury, the Optical coherence tomography can determine the change of the airway tissues and severity of airway injury.

During endoscopic procedure the lesions will be biopsied and prepared by standard histologic methods. The Optical coherence tomography endoscopic imaging can measured histologic of the tissue samples and compared to standard histologic examination. The Optical coherence tomography endoscopic imaging can measured the epithelial thickness and compared to visual inspection of the mucosa on bronchoscopy.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: July 2018
• Est. primary completion date: July 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult 18 or older, male or female.

• Plans for bronchoscopic with possible biopsy procedures.

Exclusion Criteria:

• Age less than 18 years of age

• Not plan for bronchoscopic with possible biopsy procedures.

• Pregnant or breastfeeding.

Related Conditions & MeSH terms

• Disease
• Disorder of Pleura and Pleural Cavity
• Pleural Diseases

Intervention

Device:
• Optical Coherence Tomography imaging
Optical Coherence Tomography imaging

Locations

Country	Name	City	State
United States	Pulmonary and Critical Care Medicine	Irvine	California

Sponsors (2)

Lead Sponsor	Collaborator
University of California, Irvine	Beckman Laser Institute University of California Irvine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	histopathology		up to 4 weeks